Therapix jumps on cannabis pharmaceutical acquisition

medical cannabis

Lara Pharm is developing the active ingredient in cannabis to work in an inhaler.

Therapix Biosciences Ltd. (TASE: TRPH) (formerly NasVax) share price jumped 16.85% today to NIS 0.62 on news that it is to acquire medical cannabis developer Lara Pharm Ltd..

In the first stage Therapix invested $800,000 for 26% of Lara Pharm. The company is now buying a further 49% for $1.5 million.

Lara Pharm is developing a formulation of THC, the active ingredient in cannabis, to work in an inhaler.

Published by Globes [online], Israel business news - - on August 11, 2014

© Copyright of Globes Publisher Itonut (1983) Ltd. 2014

medical cannabis
medical cannabis
Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018